Moderna Faces Bearish Options Activity Amid Mixed Analyst Ratings

Moderna sees significant bearish activity with 50% of traders indicating downward sentiment in options trades. The stock's current positioning may influence investor perceptions and drive stock price fluctuations.

Date: 20-03-2025

AI Rating: 5

Moderna's Options Activity reveals a notable bearish inclination among investors. Out of the unusual trades analyzed, 50% of traders showed bearish tendencies compared to 40% bullish. With a total of 10 unusual trades recorded, 8 were puts valued at approximately $977,910, while only 2 calls were noted, totaling around $135,544.

The predicted price range for Moderna extends from $25.0 to $150.0 over recent months, suggesting significant investor anxiety regarding price volatility.

The open interest for options indicates an average of 3,553.6 with a volume of 24,794.00, showcasing a robust level of engagement in options trading for this stock.

Regarding current performance, MRNA’s trading volume reached 2,111,612 with its stock price incrementally rising by 0.24% to $33.4, indicating a stable position amidst mixed signals. However, an expected earnings announcement in 42 days may provoke further investor activity and influence stock pricing.Analyst Ratings reflect a split perspective; with one UBS analyst holding a Buy rating and a target price of $78, while Citigroup downgraded its rating to Neutral, with a revised target of $40. This divergence highlights differing sentiments about Moderna's future performance.

Overall, the bearish sentiment in options trading combined with the mixed signals from analysts suggests potential pressure on Moderna's stock price in the near term, warranting caution from investors.

Stocks: MRNA